{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:39:49Z","timestamp":1791884389442,"version":"4.3.4"},"reference-count":4,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijn.ijn_358_18","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T14:13:58Z","timestamp":1567606438000},"page":"53","source":"Crossref","is-referenced-by-count":8,"title":["Therapy with the combination of tolvaptan and furosemide for refractory edema in nephrotic syndrome"],"prefix":"10.25259","volume":"30","author":[{"given":"Pankaj","family":"Hari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.266085-1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/FJC.0b013e318074f934","article-title":"Pharmacokinetic and pharmacodynamic interaction between tolvaptan, a non-peptide AVP antagonist, and furosemide or hydrochlorothiazide","author":"Shoaf","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"key-10.4103\/0971-4065.266085-2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00467-013-2687-1","article-title":"Tolvaptan therapy for massive edema in a patient with nephrotic syndrome","author":"Shimizu","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/0971-4065.266085-3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12876-015-0297-z","article-title":"The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: A meta-analysis of randomized controlled trials","author":"Yan","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"key-10.4103\/0971-4065.266085-4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/nep.13390","article-title":"Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide","author":"Takada","year":"2018","journal-title":"Nephrol Carlton"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:47:38Z","timestamp":1712173658000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/therapy-with-the-combination-of-tolvaptan-and-furosemide-for-refractory-edema-in-nephrotic-syndrome\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":4,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["266085"],"URL":"https:\/\/doi.org\/10.4103\/ijn.ijn_358_18","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}